BIOXCEL THERAPEUTICS INC (BTAI) Institutional Ownership Changes & 13F Activity
BIOXCEL THERAPEUTICS INC (BTAI). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2022). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Renaissance Technologies LLC and Fmr Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Fmr Llc | Buy | +5,811 | +0.1% | 4,203,436 | $90.29M | Q4 2022 | Nov 05, 2026 |
| Renaissance Technologies LLC | Sell | -35,500 | -100.0% | 0 | $0.00 | Q4 2022 | Nov 14, 2022 |
Frequently asked questions about BTAI activity
Which institutional owners are buying BTAI?
Institutional owners buying BTAI include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in BTAI activity?
"Buy" means an investor increased their reported position in BTAI compared to the prior reporting period. This reflects growing exposure to BIOXCEL THERAPEUTICS INC (BTAI) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in BTAI increasing?
Institutional interest in BTAI can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.